Phase II study of cystemustine in advanced renal cancer.
Chauvergne J, Kerbrat P, Adenis A, Chollet P, Fargeot P, Pujade-Lauraine E, Dieras V, Madelmont JC, Lentz MA, Toulouse C, et al.
Chauvergne J, et al. Among authors: toulouse c.
Eur J Cancer. 1995;31A(1):130-1. doi: 10.1016/0959-8049(94)00375-f.
Eur J Cancer. 1995.
PMID: 7695969
Clinical Trial.
No abstract available.